Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0M2GQ
|
|||
Former ID |
DIB013709
|
|||
Drug Name |
ISS-1018
|
|||
Indication | Lymphoma [ICD-11: 2A80-2A86; ICD-9: 202.8, 208.9] | Phase 3 | [1] | |
Company |
Dynavax Technologies
|
References | Top | |||
---|---|---|---|---|
REF 1 | Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov. 2006 Jun;5(6):471-84. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.